|
AP1S2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.324600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.918400E-01 |
| Normal-vs-Stage2 |
3.503400E-01 |
| Normal-vs-Stage3 |
5.963000E-01 |
| Normal-vs-Stage4 |
4.524200E-01 |
| Stage1-vs-Stage2 |
1.003780E-01 |
| Stage1-vs-Stage3 |
1.446830E-01 |
| Stage1-vs-Stage4 |
1.394220E-01 |
| Stage2-vs-Stage3 |
6.315800E-01 |
| Stage2-vs-Stage4 |
8.891600E-01 |
| Stage3-vs-Stage4 |
7.494800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.658600E-01 |
| Normal-vs-AfricanAmerican |
6.738000E-01 |
| Normal-vs-Asian |
6.346400E-01 |
| Caucasian-vs-AfricanAmerican |
5.690200E-01 |
| Caucasian-vs-Asian |
6.979400E-01 |
| AfricanAmerican-vs-Asian |
3.950600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.040600E-01 |
| Normal-vs-Female |
8.519800E-01 |
| Male-vs-Female |
6.888600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.990600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.836000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.336600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.116600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.701000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.016200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.185000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.285800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.321800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.636400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.593800E-01 |
| Classical-VS-Follicular |
1.406210E-02 |
| Classical-VS-Other |
2.260400E-01 |
| Classical-VS-Normal |
6.685400E-01 |
| Tall-VS-Follicular |
8.211900E-02 |
| Tall-VS-Other |
1.857960E-01 |
| Tall-VS-Normal |
5.851000E-01 |
| Follicular-VS-Other |
6.871200E-01 |
| Follicular-VS-Normal |
1.783030E-01 |
| Other-VS-Normal |
3.088600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.535800E-01 |
| Normal-vs-N1 |
6.177600E-01 |
| N0-vs-N1 |
9.664600E-01 |
|
|
